Relevant Interviews, Disease and Trial Updates and Stock-Markets News posted by CRISPR Medicine News.

Check also Companies to Follow in 2022 and CMN Markets for the latest stock and market trends.

Always stay updated with the free CMN Newsletter.

Spotlight Therapeutics

Main focus: In vivo gene therapies

Company stage: Pre-clinical

Diseases: Ocular diseases, haemoglobinopathies and immunooncology

Genome editing tool: CRISPR (undisclosed type)

Funding stage: Private

Location: San Francisco Bay Area, CA, USA



Spotlight Therapeutics is an early stage pre-clinical gene-editing company. Spotlight is focused on developing first-in-class in vivo gene-editing therapeutics. To do this it uses its proprietary technology platform Targeted Active Gene Editors (TAGE). The TAGE platform allows the company to address both delivery and in vivo CRISPR editing shortcomings.


HashtagSpotlight Therapeutics

The CMN Collection of Delivery Articles
Company: Spotlight Therapeutics
Jobs, banner ads, webinars, sponsored content...
Search CRISPR Medicine